Market revenue in 2022 | USD 342.5 million |
Market revenue in 2030 | USD 998.7 million |
Growth rate | 14.3% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.39% in 2022. Horizon Databook has segmented the India molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
According to the India Brand Equity Foundation, Indian biotechnology industry ranks third in the Asia Pacific region. Indian biotechnology sector is growing at faster rate and is expected to witness lucrative growth in the coming years owing to increasing initiatives by government and expansion activities by key manufacturers in the country.
In recent years, Indian biopharma industry has witnessed significant growth. Such growing biotechnology and biopharmaceutical industry in India is expected to boost the market for molecular biology enzymes, kits, and reagents in the country.
Moreover, the companies such as QIAGEN, Thermo Fisher Scientific, and Agilent Technologies have expanded their business in the country through various strategic initiatives. For instance, in January 2020, Agilent Technologies collaborated with Indian Institute of Technology Delhi to enhance biopharmaceutical research.
Horizon Databook provides a detailed overview of country-level data and insights on the India molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into India molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account